These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 17941186

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vivo synergy of cardiotoxin and phospholipase A2 from the elapid snake Naja mossambica mossambica.
    Bougis PE, Marchot P, Rochat H.
    Toxicon; 1987; 25(4):427-31. PubMed ID: 3617080
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Factors influencing the hemolysis of human erythrocytes by cardiotoxins from Naja naja kaouthia and Naja naja atra venoms and a phospholipase A2 with cardiotoxin-like activities from Bungarus fasciatus venom.
    Jiang MS, Fletcher JE, Smith LA.
    Toxicon; 1989; 27(2):247-57. PubMed ID: 2718193
    [Abstract] [Full Text] [Related]

  • 9. Characterization of elapidae snake venom components using optimized reverse-phase high-performance liquid chromatographic conditions and screening assays for alpha-neurotoxin and phospholipase A2 activities.
    Bougis PE, Marchot P, Rochat H.
    Biochemistry; 1986 Nov 04; 25(22):7235-43. PubMed ID: 3801413
    [Abstract] [Full Text] [Related]

  • 10. Immobilized betulinic acid column and its interactions with phospholipase A2 and snake venom proteins.
    Tseng HC, Liu YC.
    J Sep Sci; 2004 Oct 04; 27(14):1215-20. PubMed ID: 15537079
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Elucidation of the solution structure of cardiotoxin analogue V from the Taiwan cobra (Naja naja atra)--identification of structural features important for the lethal action of snake venom cardiotoxins.
    Jayaraman G, Kumar TK, Tsai CC, Srisailam S, Chou SH, Ho CL, Yu C.
    Protein Sci; 2000 Apr 04; 9(4):637-46. PubMed ID: 10794406
    [Abstract] [Full Text] [Related]

  • 13. Biochemical and pharmacological properties of cardiotoxins isolated from cobra venom.
    Hider RC, Khader F.
    Toxicon; 1982 Apr 04; 20(1):175-9. PubMed ID: 7080031
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Snake venom cardiotoxins and bee venom melittin activate phospholipase C activity in primary cultures of skeletal muscle.
    Fletcher JE, Jiang MS, Gong QH, Smith LA.
    Biochem Cell Biol; 1991 Apr 04; 69(4):274-81. PubMed ID: 2054159
    [Abstract] [Full Text] [Related]

  • 16. Naja mossambica mossambica venom. Purification, some properties and the amino acid sequences of three phospholipases A (CM-I, CM-II and CM-III).
    Joubert FJ.
    Biochim Biophys Acta; 1977 Jul 22; 493(1):216-27. PubMed ID: 880314
    [Abstract] [Full Text] [Related]

  • 17. Effect of phospholipase A on actions of cobra venom cardiotoxins on erythrocytes and skeletal muscle.
    Harvey AL, Hider RC, Khader F.
    Biochim Biophys Acta; 1983 Feb 22; 728(2):215-21. PubMed ID: 6830777
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.